Dry Eye Syndrome Market Estimated to Exceed US$ 5.1 Billion Globally By 2024: IMARC Group

Global Dry Eye Syndrome Market Research Report and Forecast 2024

Report Edition: 2019 © 2019 IMARC All Rights Reserved

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Global Dry Eye Syndrome Market Overview: As per the latest report by IMARC Group, titled “Dry Eye Syndrome Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024�, the global dry eye syndrome market size reached US$ 3.5 Billion in 2018. Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), refers to a condition in which the patient experiences a lack of lubrication or moisture on the surface of their eyes. The symptoms include aching and burning sensations, soreness, redness, fatigue, and itching in the eyes, along with photophobia. Moreover, watery eyes can also be a symptom of this condition as the dry eye surface can over-stimulate the production of the watery component of tears to reduce dryness.

Dry Eye Syndrome Market Trends Reliance on electronic gadgets like computers and smartphones is one of the primary factors increasing the prevalence of dry eye syndrome. Prolonged usage of these devices results in strained eyes, diminished visual alertness, and mucosal dryness or burning sensation. Additionally, continuous staring at these devices can decrease the stability of the tear film and cause ocular discomfort. As per statistics, approximately 425-430 million individuals around the world get affected by diabetes.

Report Description and Highlights

157.3 146.7 152.0 141.4 136.1 125.5 130.8

160 140 120 100 80 60 40 20 0

120.2 2011

2012

2013

2014

2015

2016

2017

2018

In Billion US$

in Billion US$

Report Description

180 160 140 120 100 80 60 40 20 0

160.0 2019

170.6

175.9

181.2

186.5

165.3

2020

2021

2022

2023

2024

It causes constant changes in the composition of the patient’s blood, thereby adversely affecting their tear glands. On account of these factors, the market value is projected to reach US$ 5.1 Billion by 2024, expanding at a CAGR of around 6.5% during 2019-2024.

Request for a free sample https://www.imarcgroup.com/dry-eye-syndrome-market/requestsample

report:

Report Description and Highlights

Report Description

Apart from this, numerous diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma and rheumatoid arthritis, increase the chances of developing dry eyes among patients.

For more information, click here: https://www.imarcgroup.com/dry-eye-syndrome-market Key Market Segmentation: Market Segmentation by Disease Type • •

Evaporative Dry Eye Syndrome Aqueous Dry Eye Syndrome

Based on the disease type, the market has been bifurcated into evaporative and aqueous dry eye syndrome. At present, evaporative dry eye syndrome represents the most common disease type.

Market Segmentation by Drug Type • •

Lubricant Eye Drops Anti-inflammatory Drugs

Report Description and Highlights

Report Description •

Autologous Serum Eye Drops

On the basis of the drug type, the market has been segregated into lubricant eye drops, antiinflammatory drugs and autologous serum eye drops. Currently, anti-inflammatory drugs represent the largest segment as they aid in reducing the ocular surface inflammation that is commonly associated with dry eye syndrome.

Market Segmentation by Product • • • • •

Liquid Drops Gel Liquid Wipes Eye Ointment Others

Based on the product, the market has been segmented into liquid drops, gels, liquid wipes, eye ointment and others. The report finds that liquid eye drops account for the majority of the total market share.

Report Description and Highlights

Report Description

Market Segmentation by Distribution Channel • • •

Pharmacies Hospital Pharmacies Online Pharmacies

The market has been analyzed on the basis of the distribution channel into retail, hospital and online pharmacies. Amongst these, hospital pharmacies exhibit a clear dominance in the market.

Market Segmentation by Region • • • • •

North America Europe Asia Pacific Middle East and Africa Latin America

Region-wise, North America is the largest market for dry eye syndrome owing to the large patient pool,

Report Description and Highlights

Report Description

an increase in the usage of digital devices and the presence of several key players in the region. Other major markets include Asia Pacific, Latin America, Middle East and Africa and Europe.

Competitive Landscape: The competitive landscape of the market has also been examined with some of the key players.

• • • • • • • • • •

Novartis AG Allergan plc.

Otsuka Holdings Co., Ltd. Santen Pharmaceutical Co., Ltd. Nicox S.A. Auven Therapeutics Akorn, Inc. Bausch + Lomb Alimera Science GlaxoSmithKline plc

Report Description and Highlights

Report Description Browse Related Report

Wound Care Biologics Market Report: https://www.imarcgroup.com/wound-care-biologics-market H1N1 Vaccines Market Report: https://www.imarcgroup.com/h1n1-vaccines-market

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

Š 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com